HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility

Li,Yuchun; Wang,Kaijuan; Dai,Liping; Wang,Peng; Song,Chunhua; Shi,Jianxiang; Ren,Pengfei; Ye,Hua; Zhang,Jianying

doi:10.3892/ol.2012.728

HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility

Authors:
- Yuchun Li
- Kaijuan Wang
- Liping Dai
- Peng Wang
- Chunhua Song
- Jianxiang Shi
- Pengfei Ren
- Hua Ye
- Jianying Zhang
View Affiliations

Affiliations: Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou 450001, P.R. China, Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Biological Sciences, University of Texas, El Paso, TX 79968, USA
Published online on: May 23, 2012 https://doi.org/10.3892/ol.2012.728
Pages: 358-364

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

CIP2A is a human oncoprotein that inhibits PP2A and stabilizes c-myc in human malignancies. Autoantibodies to CIP2A protein have been reported to be present in higher levels in sera from patients with hepatocellular carcinoma (HCC) than in sera of healthy individuals. The CIP2A gene has been demonstrated as a potential cancer susceptibility gene. To elucidate whether common CIP2A variants are associated with HCC susceptibility, we conducted a case-control study comprising 233 cases of HCC and 280 controls matched on age, gender and ethnicity in the Chinese Han population. Two haplotype-tagging single nucleotide polymorphisms (htSNPs) (rs2278911 and rs4855656) from the HapMap database were analyzed, which provide an almost complete coverage of the genetic variations in the CIP2A gene. We found that neither of these htSNPs and haplotypes were associated with the risk of HCC. However, an interaction was observed between hepatitis virus B and C infection (HBV and HCV) and the C carriers (TC or CC) of rs2278911 on HCC risk (OR=12.35; 95% CI, 4.93-19.87). No such association was found for rs4855656. Our study also demonstrated that two htSNPs (rs2278911 and rs4855656) in the CIP2A gene are not associated with the risk of HCC. HBV and HCV infection was found to exert a synergistic effect on the risk of HCC in individuals with the C carriers (TC or CC) of rs2278911 in the Chinese Han population.

View Figures

View References

1	El-Serag HB and Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 1329:2557–2576. 2007. View Article : Google Scholar
2	Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol. 25:657–663. 2010. View Article : Google Scholar : PubMed/NCBI
3	International Agency for Research on Cancer. GLOBOCAN. 2008, Geneva: WHO. Available at http://www-dep.iarc.fr/.
4	Mori M, Hara M, Wada I, Hara I, Yamamoto K, Honda M and Naramoto J: Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol. 151:131–139. 2000. View Article : Google Scholar
5	Yuan JM, Govindarajan S, Arakawa K and Yu MC: Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer. 101:1009–1017. 2004. View Article : Google Scholar : PubMed/NCBI
6	Jee SH, Ohrr H, Sull JW and Samet JM: Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst. 96:1851–1856. 2004. View Article : Google Scholar : PubMed/NCBI
7	Kuper H, Tzonou A, Kaklamani E, et al: Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer. 85:498–502. 2000. View Article : Google Scholar : PubMed/NCBI
8	Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL and Lok AS: Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 42:218–224. 2005. View Article : Google Scholar : PubMed/NCBI
9	Zhang JY, Dai M, Wang X, et al: A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol. 27:574–578. 1998. View Article : Google Scholar : PubMed/NCBI
10	Zhang JY, Wang X, Han SG and Zhuang H: A case-control study of risk factors for hepatocellular carcinoma in Henan, China. Am J Trop Med Hyg. 59:947–951. 1998.PubMed/NCBI
11	Budhu A and Wang XW: The role of cytokines in hepatocellular carcinoma. J Leukoc Biol. 80:1197–1213. 2006. View Article : Google Scholar : PubMed/NCBI
12	Giacalone A, Montalto G, Giannitrapani L, et al: Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. OMICS. 15:193–196. 2011.
13	Li S, Deng Y, Chen ZP, et al: Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Infect Genet Evol. 11:2083–2088. 2011. View Article : Google Scholar : PubMed/NCBI
14	Chinen MH, Yeh CB, Li YC, et al: Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol. 104:798–803. 2011. View Article : Google Scholar : PubMed/NCBI
15	Sümbül AT, Akkiz H, Bayram S, Bekar A, Akqöllü E and Sandıkçı M: p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep. 39:1639–1647. 2012.PubMed/NCBI
16	Chakravarti A: Population genetics - making sense out of sequence. Nat Genet. 21:56–60. 1999. View Article : Google Scholar : PubMed/NCBI
17	Ikeda M, Iwata N, Kitajima T, Suzuki T, Yamanouchi Y, Kinoshita Y and Ozaki N: Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology. 31:866–871. 2006. View Article : Google Scholar : PubMed/NCBI
18	The International HapMap Consortium. A haplotype map of the human genome. Nature. 437:1299–1320. 2005. View Article : Google Scholar
19	International HapMap Consortium. Frazer KA, Ballinqer DG, et al: A second generation human haplotype map of over 3.1 million SNPs. Nature. 449:851–861. 2007. View Article : Google Scholar : PubMed/NCBI
20	de Bakker PI, Burtt NP, Graham RR, et al: Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet. 38:1298–1303. 2006.PubMed/NCBI
21	Soo Hoo L, Zhang JY and Chan EK: Cloning and characterization of a novel 90 kDa ‘companion’ auto-antigen of p62 overexpressed in cancer. Oncogene. 21:5006–5015. 2002.
22	Zhang JY, Wang X, Peng XX and Chan EK: Autoantibody responses in Chinese hepatocellular carcinoma. J Clin Immunol. 22:98–105. 2002. View Article : Google Scholar : PubMed/NCBI
23	Junttila MR, Puustinen P, Niemelä M, et al: CIP2A inhibits PP2A in human malignancies. Cell. 130:51–62. 2007. View Article : Google Scholar : PubMed/NCBI
24	Ye S, Dhillon S, Ke X, Collins AR and Dav IN: An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res. 29:E88–8. 2001. View Article : Google Scholar : PubMed/NCBI
25	Little S: Amplification-refractory mutation system (ARMS) analysis of point mutations. Curr Protoc Hum Genet. Chapter 9(Unit 9): 82001.PubMed/NCBI
26	Rothman KJ: The estimation of synergy or antagonism. Am J Epidemiol. 103:506–511. 1976.PubMed/NCBI
27	Han W, Kang D, Lee JE, et al: A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Clin Cancer Res. 11:4775–4778. 2005. View Article : Google Scholar : PubMed/NCBI
28	Hu Z, Xu L, Shao M, et al: Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Cancer Epidemiol Biomarkers Prev. 15:1336–1340. 2006. View Article : Google Scholar : PubMed/NCBI
29	Kirk GD, Bah E and Montesano R: Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis. 27:2070–2082. 2006. View Article : Google Scholar : PubMed/NCBI
30	Brechot C, Kremsdorf D, Soussan P, Pineau P, Dejean A, Paterlini-Brechot P and Tiollais P: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. Pathol Biol (Paris). 58:278–287. 2010. View Article : Google Scholar : PubMed/NCBI
31	Koike K: Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J Gastroenterol Hepatol. 22:S108–S111. 2007. View Article : Google Scholar : PubMed/NCBI